IGF1R and ovarian epithelial tumor: In malignant epithelial ovarian tumors, the positive rate of IGF-1R detection (93.33%) was significantly higher than those in marginal (63.33%) (P < 0.05), benign (53.33%) (P < 0.05), and normal ovarian samples (40%) (P < 0.01).